3 results
Approved WMOCompleted
Primary Objective:To induce clinical response (CDAI decrease from baseline * 100 points) and/or remission(CDAI <150) following 12 weeks of treatment with one of two active doses ofGSK1605786A for qualification of subjects for enrolment into a…
Approved WMOWill not start
Primary: Safety and tolerability. Secondary: Effectiveness, quality of life, healthcare resource utilisation, work productivity.
Approved WMOCompleted
Primary Objective1. Investigate the feasibility of intraoperative imaging with CBCT in open maxillectomy for verifying resection of the intended treatment volume. 2. Assess the feasibility of the intended treatment volume segmentation and resection…